{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:28:54Z","timestamp":1790749734521,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.vaccine.2010.02.095","type":"journal-article","created":{"date-parts":[[2010,4,2]],"date-time":"2010-04-02T08:25:16Z","timestamp":1270196716000},"page":"3778-3783","source":"Crossref","is-referenced-by-count":43,"title":["The global introduction of inactivated polio vaccine can circumvent the oral polio vaccine paradox"],"prefix":"10.1016","volume":"28","author":[{"given":"Ellen","family":"Heinsbroek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Joost","family":"Ruitenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"May (5775)","key":"10.1016\/j.vaccine.2010.02.095_bib1","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1126\/science.1124959","article-title":"Public health. Is polio eradication realistic?","volume":"312","author":"Arita","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2010.02.095_bib2","series-title":"Wild poliovirus weekly update [online]","author":"Global Polio Eradication Initiative","year":"2010"},{"issue":"February (5915)","key":"10.1016\/j.vaccine.2010.02.095_bib3","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1126\/science.323.5915.702","article-title":"Polio eradication. Looking for a little luck","volume":"323","author":"Roberts","year":"2009","journal-title":"Science"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2010.02.095_bib4","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1086\/593310","article-title":"New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis","volume":"47","author":"Chumakov","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2010.02.095_bib5","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nrmicro1769","article-title":"Vaccination against polio should not be stopped","volume":"5","author":"Chumakov","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"May (20)","key":"10.1016\/j.vaccine.2010.02.095_bib6","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.vaccine.2009.02.071","article-title":"Vaccine-derived poliovirus (VDPV): impact on poliomyelitis eradication","volume":"27","author":"Minor","year":"2009","journal-title":"Vaccine"},{"issue":"July (28)","key":"10.1016\/j.vaccine.2010.02.095_bib7","first-page":"241","article-title":"Introduction of inactivated poliovirus vaccine into oral poliovirus vaccine-using countries","volume":"78","year":"2003","journal-title":"Wkly Epidemiol Rec"},{"issue":"October (5748)","key":"10.1016\/j.vaccine.2010.02.095_bib8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1126\/science.1115547","article-title":"Policy, OPV cessation\u2014the final step to a \u201cpolio-free\u201d world","volume":"310","author":"Aylward","year":"2005","journal-title":"Science"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2010.02.095_bib9","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1539-6924.2006.00827.x","article-title":"Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication","volume":"26","author":"Tebbens","year":"2006","journal-title":"Risk Anal"},{"key":"10.1016\/j.vaccine.2010.02.095_bib10","series-title":"Circulating vaccine-derived poliovirus 2000\u20132009","author":"GPEI","year":"2009"},{"issue":"September (36)","key":"10.1016\/j.vaccine.2010.02.095_bib11","first-page":"1002","article-title":"Update on vaccine-derived polioviruses\u2014worldwide, January 2008\u2013June 2009","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"February (5915)","key":"10.1016\/j.vaccine.2010.02.095_bib12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.323.5915.705","article-title":"Polio eradication. Rethinking the polio endgame","volume":"323","author":"Roberts","year":"2009","journal-title":"Science"},{"issue":"September (39)","key":"10.1016\/j.vaccine.2010.02.095_bib13","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1016\/j.vaccine.2008.07.026","article-title":"World wide experience with inactivated poliovirus vaccine","volume":"26","author":"Bonnet","year":"2008","journal-title":"Vaccine"},{"issue":"April (15)","key":"10.1016\/j.vaccine.2010.02.095_bib14","first-page":"137","article-title":"Inactivated poliovirus vaccine following oral poliovirus vaccine cessation","volume":"81","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2010.02.095_bib15","series-title":"Assembly WH. Resolution WHA61.1. Poliomyelitis: mechanism for management of potential risks to eradication","year":"2008"},{"key":"10.1016\/j.vaccine.2010.02.095_bib16","series-title":"Global post-eradication IPV supply and demand assessment: integrated findings","author":"Wyman","year":"2009"},{"key":"10.1016\/j.vaccine.2010.02.095_bib17","series-title":"Global Polio Eradication Initiative","author":"GPEI","year":"2009"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.02.095_bib18","first-page":"40","article-title":"Framework for evaluating the risks of paralytic poliomyelitis after global interruption of wild poliovirus transmission","volume":"82","author":"Aylward","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2010.02.095_bib19","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1539-6924.2006.00855.x","article-title":"Perspective: determinants of the severity of poliovirus outbreaks in the post eradication era","volume":"26","author":"Fine","year":"2006","journal-title":"Risk Anal"},{"key":"10.1016\/j.vaccine.2010.02.095_bib20","first-page":"129","article-title":"Stopping a polio outbreak in the post-eradication era","volume":"105","author":"Fine","year":"2001","journal-title":"Dev Biol (Basel)"},{"issue":"July\u2013August (4)","key":"10.1016\/j.vaccine.2010.02.095_bib21","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1377\/hlthaff.28.4.1079","article-title":"Polio eradication: strengthening the weakest links","volume":"28","author":"Barrett","year":"2009","journal-title":"Health Aff (Millwood)"},{"issue":"April (9570)","key":"10.1016\/j.vaccine.2010.02.095_bib22","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(07)60533-9","article-title":"Global poliomyelitis eradication: status and implications","volume":"369","author":"Fine","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.02.095_bib23","series-title":"FAQs on OPV Cessation","author":"Global Polio Eradication Initiative","year":"2009"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2010.02.095_bib24","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/ije\/30.5.1029","article-title":"Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication","volume":"30","author":"Mas Lago","year":"2001","journal-title":"Int J Epidemiol"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2010.02.095_bib25","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/ije\/dyg185","article-title":"Poliovirus detection in wastewater and stools following an immunization campaign in Havana, Cuba","volume":"32","author":"Mas Lago","year":"2003","journal-title":"Int J Epidemiol"},{"issue":"December (23)","key":"10.1016\/j.vaccine.2010.02.095_bib26","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1128\/JVI.77.23.12460-12465.2003","article-title":"Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the future","volume":"77","author":"Korotkova","year":"2003","journal-title":"J Virol"},{"issue":"September (18)","key":"10.1016\/j.vaccine.2010.02.095_bib27","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1128\/AEM.02764-07","article-title":"Isolation of sabin-like polioviruses from wastewater in a country using inactivated polio vaccine","volume":"74","author":"Zurbriggen","year":"2008","journal-title":"Appl Environ Microbiol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2010.02.095_bib28","doi-asserted-by":"crossref","first-page":"8089","DOI":"10.1128\/JVI.68.12.8089-8101.1994","article-title":"High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis","volume":"68","author":"Georgescu","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.02.095_bib29","series-title":"Vaccines","first-page":"605","article-title":"Poliovirus vaccine-inactivated","author":"Plotkin","year":"2008"},{"issue":"1","key":"10.1016\/j.vaccine.2010.02.095_bib30","first-page":"2","article-title":"Eliminating needles","author":"WHO","year":"2008","journal-title":"the PolioPipeline"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.02.095_bib31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2471\/BLT.06.037457","article-title":"Global eradication of polio: the case for \u201cfinishing the job\u201d","volume":"85","author":"Lahariya","year":"2007","journal-title":"Bull World Health Organ"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.02.095_bib32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/14760584.8.1.5","article-title":"Role of injectable and oral polio vaccines in polio eradication","volume":"8","author":"John","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2010.02.095_bib33","first-page":"253","article-title":"Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines","volume":"74","year":"1996","journal-title":"Bull World Health Organ"},{"issue":"April (15)","key":"10.1016\/j.vaccine.2010.02.095_bib34","first-page":"1536","article-title":"Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2010.02.095_bib35","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/520546","article-title":"Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants","volume":"196","author":"Asturias","year":"2007","journal-title":"J Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.02.095_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1086\/508427","article-title":"Serologic response to inactivated poliovirus vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico","volume":"195","author":"Dayan","year":"2007","journal-title":"J Infect Dis"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2010.02.095_bib37","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1086\/605331","article-title":"Polio: measuring the protection that matters most","volume":"200","author":"Fine","year":"2009","journal-title":"J Infect Dis"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2010.02.095_bib38","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1086\/498172","article-title":"Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains","volume":"192","author":"Laassri","year":"2005","journal-title":"J Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.02.095_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/163.1.1","article-title":"Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines","volume":"163","author":"Onorato","year":"1991","journal-title":"J Infect Dis"},{"issue":"July (29\u201330)","key":"10.1016\/j.vaccine.2010.02.095_bib40","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1016\/j.vaccine.2006.05.032","article-title":"The cost-effectiveness of alternative polio immunization policies in South Africa","volume":"24","author":"Griffiths","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2010.02.095_bib41","first-page":"2","article-title":"Improving IPV","author":"WHO","year":"2008","journal-title":"the PolioPipeline"},{"issue":"May\u2013June (3)","key":"10.1016\/j.vaccine.2010.02.095_bib42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4161\/hv.3.3.4057","article-title":"Inactivated poliovirus vaccine","volume":"3","author":"Arya","year":"2007","journal-title":"Hum Vaccin"},{"issue":"3","key":"10.1016\/j.vaccine.2010.02.095_bib43","first-page":"3","article-title":"Update on improving IPV","author":"WHO","year":"2009","journal-title":"the PolioPipeline"},{"issue":"3","key":"10.1016\/j.vaccine.2010.02.095_bib44","first-page":"1","article-title":"Polio Research Committee outcomes","author":"WHO","year":"2009","journal-title":"the PolioPipeline"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2010.02.095_bib45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.biologicals.2006.02.011","article-title":"Technology transfer of Sabin-IPV to new developing country markets","volume":"34","author":"Kreeftenberg","year":"2006","journal-title":"Biologicals"},{"issue":"3","key":"10.1016\/j.vaccine.2010.02.095_bib46","first-page":"4","article-title":"The poliovirus antivirals initiative","author":"WHO","year":"2009","journal-title":"the PolioPipeline"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2010.02.095_bib47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.antiviral.2008.04.002","article-title":"A case for developing antiviral drugs against polio","volume":"79","author":"Collett","year":"2008","journal-title":"Antiviral Res"},{"issue":"October (45)","key":"10.1016\/j.vaccine.2010.02.095_bib48","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1016\/j.vaccine.2008.07.101","article-title":"Epidemiology of poliomyelitis\u2014options and update","volume":"26","author":"Dutta","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.02.095_bib49","series-title":"GAVI\/VF long-term vaccine supply strategy. Recommendations from the GAVI\/VF Secretariat","author":"GAVI","year":"2005"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10002914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10002914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T13:12:25Z","timestamp":1591189945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10002914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":49,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0264410X10002914"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.02.095","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}